SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
13
Employees13
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
13
Employees13

SLS Key Statistics

Market cap
2.37B
Market cap2.37B
Price-Earnings ratio
-55.87
Price-Earnings ratio-55.87
Dividend yield
Dividend yield
Average volume
15.19M
Average volume15.19M
High today
$13.66
High today$13.66
Low today
$12.49
Low today$12.49
Open price
$13.27
Open price$13.27
Volume
6.41M
Volume6.41M
52 Week high
$15.88
52 Week high$15.88
52 Week low
$1.39
52 Week low$1.39

Stock Snapshot

SELLAS Life Sciences(SLS) stock is priced at $12.78, giving the company a market capitalization of 2.37B. It carries a P/E multiple of -55.87.

On 2026-07-12, SELLAS Life Sciences(SLS) stock moved within a range of $12.49 to $13.66. With shares now at $12.78, the stock is trading +2.3% above its intraday low and -6.4% below the session's peak.

Trading volume for SELLAS Life Sciences(SLS) stock has reached 6.41M, versus its average volume of 15.19M.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

SLS News

Simply Wall St 3d
Galinpepimut-S REGAL Readout and Deal Chatter Might Change The Case For Investing In SELLAS

In recent comments, SELLAS Life Sciences Group CEO Angelos M. Stergiou addressed concerns about perceived delays in the pivotal Phase 3 REGAL trial for Galinpep...

Galinpepimut-S REGAL Readout and Deal Chatter Might Change The Case For Investing In SELLAS
Simply Wall St 4d
SELLAS Life Sciences Group Draws Fresh Attention, Is The Premium Already Priced In?

SELLAS Life Sciences Group (SLS) is back in focus after MassMutual disclosed a small new stake ahead of the company’s key Phase 3 REGAL AML trial readout, which...

SELLAS Life Sciences Group Draws Fresh Attention, Is The Premium Already Priced In?

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.